Commercialising Scientific Advice for MHRA

The Medicines and Healthcare Products Regulatory Agency requires consultancy to support the MHRA in responding to increasing demand, improving service quality and predictability, and ensuring the Scientific Advice offer remains competitive, sustainable, and aligned with the MHRA 2030 Strategy. The Deliverables are as follows: • Description of MHRA's unique strengths and market context; 5-10 critical hypotheses regarding potential demand and operational requirements for the MHRA to commercialise scientific advice (e...